{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T10:51:28Z","timestamp":1780570288198,"version":"3.54.1"},"reference-count":40,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2002,1,5]],"date-time":"2002-01-05T00:00:00Z","timestamp":1010188800000},"content-version":"vor","delay-in-days":1222,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Internal Medicine"],"published-print":{"date-parts":[[1998,9]]},"abstract":"<jats:sec><jats:label\/><jats:p>Valdemarsson S, Lindblom P, Bergenfelz A (Departments of Internal medicine and surgery, Lund University Hospital, Lund Sweden). Metabolic abnormalities related to cardiovascular risk in primary hyperparathyroidism: effects of surgical treatment. <jats:italic>J Intern Med<\/jats:italic> 1998; <jats:bold>244<\/jats:bold>: 241\u201349.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objectives<\/jats:title><jats:p>Untreated primary hyperarathyroidism (pHPT) is accompanied by an excessive morbidity in circulatory disorders, associated with blood pressure and diabetes. The aim of the present study was to further penetrate the impact of pHPT on glucose, urate, lipid and lipoprotein concentrations, known to be interrelated metabolic cardiovascular risk factors.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design<\/jats:title><jats:p>Longitudinal study of patients with pHPT before and 1 year after surgical treatment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Setting<\/jats:title><jats:p>Departments of Internal Medicine and Surgery, Lund University Hospital.<\/jats:p><\/jats:sec><jats:sec><jats:title>Subjects<\/jats:title><jats:p>One hundred and seventeen consecutive patients with pHPT referred to surgical treatment. At presentation, 11 patients had previously diagnosed diabetes mellitus.<\/jats:p><\/jats:sec><jats:sec><jats:title>Intervention<\/jats:title><jats:p>All patients were successfully operated for pHPT.<\/jats:p><\/jats:sec><jats:sec><jats:title>Main outcome measures<\/jats:title><jats:p>Fasting blood glucose and serum concentrations of cholesterol, triglyceride and urate were determined before and 1 year after surgery. The concentration of LDL\u2010 and HDL\u2010cholesterol was separately analyzed in 21 cases. These data as well as the systolic and diastolic blood pressure were related to intact PTH and ionized calcium at presentation. Glomerular filtation was separately measured pre\u2010operatively and related to the urate values.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>While the mean value for glucose remained unchanged among 11 patients with previously diagnosed diabetes at presentation, a significant decrease of glucose from 5.03 \u00b1 0.13 to 4.71 \u00b1 0.08 mmol\/L (<jats:italic>P<\/jats:italic> &lt; 0.05) was found among patients without known diabetes. Out of these patients, eight had diabetic glucose values at presentation, decreasing from 8.35 \u00b1 0.54 to 5.10 \u00b1 0.35 mmol\/L (<jats:italic>P<\/jats:italic> &lt; 0.05), and 12 had glucose values indicating impaired glucose tolerance, decreasing from 5.94 \u00b1 0.06 to 5.10 \u00b1 0.38 mmol\/L (<jats:italic>P<\/jats:italic> &lt; 0.05) after surgery. Total cholesterol and trigylceride concentrations were not changed. However, male patients had significantly lower triglyceride levels at follow\u2010up, 1.16 \u00b1 0.09 mmol\/L compared to 1.57 \u00b1 0.14 mmol\/L before surgery (<jats:italic>P<\/jats:italic> &lt; 0.05). Significantly lower triglyceride values were also found among patients with glucose values indicating impaired glucose tolerance at presentation. The LDL\/HDL cholesterol ratio remained normal. The serum level of urate decreased in both male and female patients after surgery, and was positively correlated to the PTH and ionized calcium values and inversely correlated to renal function before treatment. There was no significant correlation between calcium or PTH and the other metabolic variables studied.<\/jats:p><\/jats:sec>","DOI":"10.1046\/j.1365-2796.1998.00366.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T06:07:46Z","timestamp":1047449266000},"page":"241-249","source":"Crossref","is-referenced-by-count":59,"title":["Metabolic abnormalities related to cardiovascular risk in primary hyperparathyroidism: effects of surgical treatment"],"prefix":"10.1111","volume":"244","author":[{"family":"Valdemarsson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Lindblom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Bergenfelz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2002,1,5]]},"reference":[{"key":"e_1_2_5_2_2","first-page":"59","article-title":"1987; Survival and renal function in persons with untreated hypercalcaemia: a population\u2010based cohort study with 14 years follow\u2010up.","author":"Palm\u00e9r M","journal-title":"Lancet"},{"key":"e_1_2_5_3_2","first-page":"13","article-title":"1985; Causes of death in patients previously operated on for primary hyperarathyroidism.","volume":"74","author":"Ronni A","journal-title":"Ann Chir Gynecol"},{"key":"e_1_2_5_4_2","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/BF01670531","article-title":"1990; Premature death in patients operated for primary hyperparathyroidism.","volume":"14","author":"Hedb\u00e4ck G","journal-title":"World J Surg"},{"key":"e_1_2_5_5_2","first-page":"1276","article-title":"1980; Primary hyperparathyroidism: incidence, morbidity and potential economic impact in a community.","volume":"302","author":"Heath H","journal-title":"N Eng J Med"},{"key":"e_1_2_5_6_2","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1365-2362.1983.tb00116.x","article-title":"1983; Diabetes mellitus, glucose tolerance and insulin response to glucose in patients with primary hyperparathyroidism before and after parathyroidectomy.","volume":"13","author":"Ljunghall S","journal-title":"Europ J Clin Invest"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.1992.tb00955.x"},{"key":"e_1_2_5_8_2","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0272-6386(12)80030-8","article-title":"1993; Lipoprotein metabolism in renal failure.","volume":"21","author":"Attman PO","journal-title":"Am J Kidney Disease"},{"key":"e_1_2_5_9_2","first-page":"1586","article-title":"1994; Parathyroid hormone is not an inhibitor of lipoprotein lipase activity.","volume":"9","author":"Arnadottir M","journal-title":"Nephrol Dial Transplant"},{"key":"e_1_2_5_10_2","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/S0039-6060(96)80186-3","article-title":"1996; Persistent elevated serum levels of intact parathyroid hormone after operation for sporadic parathyroid adenoma: evidence of detrimental effects of severe parathyroid disease.","volume":"119","author":"Bergenfelz A","journal-title":"Surgery"},{"key":"e_1_2_5_11_2","first-page":"50","article-title":"1994; Intra\u2010operative monitoring of intact PTH during surgery for primary hyperparathyroidism.","volume":"379","author":"Bergenfelz A","journal-title":"Langenbecks Arch Chir"},{"key":"e_1_2_5_12_2","first-page":"955","article-title":"1984; Plasma clearance of a new contrast agent, iohexol: a method for the assessment of glomerular filtration rate.","volume":"104","author":"Krutz\u00e9n E","journal-title":"J Lab Clin Med"},{"key":"e_1_2_5_13_2","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1080\/00365518909091539","article-title":"1989; Age dependence of renal function: clearance of iohexol and p\u2010amino hippurate in healthy males.","volume":"49","author":"B\u00e4ck SE","journal-title":"Scand J Clin Lab Invest"},{"key":"e_1_2_5_14_2","first-page":"1","article-title":"1987; Mortality after surgery for primary hyperparathyroidism: a follow up study of 441 patients operated from 1956\u201379.","volume":"102","author":"Palm\u00e9r M","journal-title":"Surgery"},{"key":"e_1_2_5_15_2","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1365-2362.1995.tb01525.x","article-title":"1995; Clinical evaluation of total serum calcium in primary hyperparathyroidism and the risk of death after surgery.","volume":"25","author":"Hedb\u00e4ck G","journal-title":"Europ J Clin Invest"},{"key":"e_1_2_5_16_2","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/BF01658740","article-title":"1991; The influence of surgery on the risk of death in patients with primary hyperparathyroidism.","volume":"15","author":"Hedb\u00e4ck G","journal-title":"World J Surg"},{"key":"e_1_2_5_17_2","first-page":"456","article-title":"1984; Reversible hypertension in primary hyperparathyroidism: pre\u2010 and post\u2010operative blood pressure in 75 cases.","volume":"62","author":"Rindge JF","journal-title":"Klin Wochenschr"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1986.00360210073012"},{"key":"e_1_2_5_19_2","first-page":"77","article-title":"1995; Hypertension and primary hyperparathyroidism: the role of adrenergic and renin angiotensin systems.","volume":"21","author":"Gennari C","journal-title":"Miner Electrolyte Metabol"},{"key":"e_1_2_5_20_2","doi-asserted-by":"crossref","first-page":"531","DOI":"10.3109\/00365519409088565","article-title":"1994; Parathyroid hormone in blood pressure and volume homeostasis in healthy subjects, hyperparathyroidism, liver chirhosis and glomerulonephritis: a possible interaction with angiotensin II and atrial natiuretic peptide.","volume":"54","author":"Jespersen B","journal-title":"Scand J Clin Lab Invest"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0029-1211312"},{"key":"e_1_2_5_22_2","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/BF03348986","article-title":"1994; Primary hyperparathyroidism and hypertension: persistently abnormal pressor sensitivity in normotensive patients after surgical cure.","volume":"17","author":"Rodriguez\u2010Portales JA","journal-title":"J Endocrinol Invest"},{"key":"e_1_2_5_23_2","first-page":"732","article-title":"1992; Long\u2010term effects of parathyroidectomy on arterial hypertension.","volume":"16","author":"Sancho JJ","journal-title":"World J Surg"},{"key":"e_1_2_5_24_2","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1136\/pgmj.59.692.350","article-title":"1983; Changes in blood pressure and renal function after parathyroidectomy in primary hyperparathyroidism.","volume":"59","author":"Jones DB","journal-title":"Postgrad Med J"},{"key":"e_1_2_5_25_2","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1042\/cs0760289","article-title":". 1989; Hypertension and renal dysfunction in primary hyperparathyroidism: effect of parathyroidectomy.","volume":"76","author":"Salahudeen AK","journal-title":"Clinical Science"},{"key":"e_1_2_5_26_2","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1210\/jcem-41-6-1025","article-title":"1975; Hypertension in primary hyperparthyroidism; the role of renin\u2013angiotensin system.","volume":"41","author":"Brinton GS","journal-title":"J Clin endocrinol Metab"},{"key":"e_1_2_5_27_2","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/j.1464-5491.1991.tb01678.x","article-title":"1991; The prevalence of diabetes mellitus in patients with primary hyperparathyroidism and among their relatives.","volume":"8","author":"Taylor WH","journal-title":"Diabet Med"},{"key":"e_1_2_5_28_2","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1097\/00000658-198804000-00010","article-title":"1988; The relationship between primary hyperparathyroidism and diabetes mellitus.","volume":"207","author":"Bannon MP","journal-title":"Ann Surg"},{"key":"e_1_2_5_29_2","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1365-2265.1994.tb02442.x","article-title":". 1994; Impaired glucos tolerance and insulin insensitivity in primary hyperparathyroidism.","volume":"40","author":"Kumar S","journal-title":"Clin Endocrinol Oxf"},{"key":"e_1_2_5_30_2","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1365-2265.1992.tb02299.x","article-title":"1992; Insulin secretion, insulin sensitivity and hepatic insulin extraction in primary hyperarathyroidism before and after surgery.","volume":"37","author":"Kautsky\u2010Willer A","journal-title":"Clin Endocrinol"},{"key":"e_1_2_5_31_2","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1340320"},{"key":"e_1_2_5_32_2","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/BF00401195","article-title":"1992; Islet amyloid polypeptide: a novel controversy in diabetes research.","volume":"35","author":"Westermark P","journal-title":"Diabetologia"},{"key":"e_1_2_5_33_2","first-page":"435","article-title":"1987; A role for insulin in the etiology and course of hypertension.","volume":"2","author":"Reaven GM","journal-title":"Lancet"},{"key":"e_1_2_5_34_2","first-page":"1036","article-title":"1989; Pseudogout as a clue and complication in primary hyperparathyroidism.","volume":"106","author":"Geelhoed GW","journal-title":"Surgery"},{"key":"e_1_2_5_35_2","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/00000658-199509000-00017","article-title":"1995; Clinical manifestations of primary hyperparathyroidism before and after parathyroidectomy: a case control study.","volume":"222","author":"Chan AK","journal-title":"Ann Surg"},{"key":"e_1_2_5_36_2","unstructured":"Primer of the Metabolic Bone Diseases and Disorders of Mineral Metabolism. New York USA: Lippincott Raven Philadelphia 1996; 181\u201386."},{"key":"e_1_2_5_37_2","unstructured":"J Intern Med 317\u201324."},{"key":"e_1_2_5_38_2","doi-asserted-by":"publisher","DOI":"10.1530\/acta.0.0890580"},{"key":"e_1_2_5_39_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.1991.tb00403.x"},{"key":"e_1_2_5_40_2","unstructured":"Metabolic Risk Factors in Ischaemic Cardiovascular Disease. New York Raven Press USA: 1982; 35\u201348."},{"key":"e_1_2_5_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/B978-1-4832-3107-5.50008-X"}],"container-title":["Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2796.1998.00366.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2796.1998.00366.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1046\/j.1365-2796.1998.00366.x","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2796.1998.00366.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T07:50:57Z","timestamp":1694418657000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2796.1998.00366.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,9]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1998,9]]}},"alternative-id":["10.1046\/j.1365-2796.1998.00366.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2796.1998.00366.x","archive":["Portico"],"relation":{},"ISSN":["0954-6820","1365-2796"],"issn-type":[{"value":"0954-6820","type":"print"},{"value":"1365-2796","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,9]]}}}